AgaMatrix

AgaMatrix

We design, develop, and manufacture world-class products for diabetes care.

Founded 2001

Salem, United States 89 employees Debt Financing Total: $152.20M Health Care, Manufacturing +2

AgaMatrix is a leading company in the diabetes care industry, offering world-class products for diabetes management. Established in 2001, the company has made significant strides in the market, manufacturing over 8 million devices and three billion sensors. Notably, AgaMatrix developed the first FDA-cleared blood glucose meter/app for iPhone®, which garnered attention from prestigious media outlets such as the New York Times and Fast Company. The company has also formed strategic partnerships with major retailers like CVS and Kroger, as well as pharmaceutical giants including Sanofi and Perrigo. AgaMatrix's vision revolves around revolutionizing the diabetes market through constant innovations in biosensor technology and blood glucose monitoring. The company's team, comprising top-tier scientists, designers, and engineers, is committed to delivering solutions in connected health, high-accuracy blood glucose testing, and intelligent meters that offer comprehensive insights beyond mere test results. In July 2019, Perceptive Advisors made a significant investment of $56.00M in AgaMatrix through debt financing. This investment reflects the confidence of prominent investors in the company's potential to drive innovation and transformation in diabetes care. With its strong track record, robust partnerships, and commitment to innovation, AgaMatrix is poised to continue making a profound impact in the Health Care and Manufacturing industries, particularly in the United States.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	$56.00M	1	Perceptive Advisors	03 Jul 2019
Debt Financing	$32.00M	1	Prospect Capital Management	05 Oct 2017
Debt Financing	$30.00M	-		06 Feb 2015
Series C	$23.66M	2	Noble International Ltd, Collaborative Seed & Growth Partners	02 Jan 2008
Series B	$4.90M	1	incTANK Ventures	27 Apr 2007
Convertible Note	$2.94M	-		21 Feb 2005
Series A	$2.70M	2	Collaborative Fund, Tank Partners	05 Dec 2003

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

$56.00M

Perceptive Advisors

03 Jul 2019

Debt Financing

$32.00M

Prospect Capital Management

05 Oct 2017

Debt Financing

$30.00M

06 Feb 2015

Series C

$23.66M

Noble International Ltd, Collaborative Seed & Growth Partners

02 Jan 2008

Series B

$4.90M

incTANK Ventures

27 Apr 2007

Convertible Note

$2.94M

21 Feb 2005

Series A

$2.70M

Collaborative Fund, Tank Partners

05 Dec 2003

FAQ About AgaMatrix

We design, develop, and manufacture world-class products for diabetes care.

AgaMatrix was founded in 2001.

AgaMatrix is headquartered in Salem, United States.

AgaMatrix operates in Health Care, Manufacturing, Medical Devices and Mobile. Its work centres on Diabetes care, Biosensor technology, Blood glucose monitoring and Connected health.

AgaMatrix has approximately 89 employees.

AgaMatrix has completed 7 funding rounds, raising a total of $152.20M. The latest funding stage is Debt Financing.

Top alternatives and competitors to AgaMatrix include Intuity Medical, Inc., Links Medical Products, Inc., GlucoActive Sp. z o.o., HME Square, i-SENS, Inc. . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

AgaMatrix and Intuity Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About AgaMatrix

Funding Rounds & Investors (7)

AgaMatrix Alternatives & Competitors

FAQ About AgaMatrix